Home › Funds › Dauntless Investment Group, LLC › CGTX

Dauntless Investment Group, LLC position in CGTX

COGNITION THERAPEUTICS INC · Health Care

Dauntless Investment Group, LLC reported holding 371,701 shares of CGTX (COGNITION THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$427K, representing 0.34% of its reported portfolio and ranking #39 among its reported holdings. Dauntless Investment Group, LLC has disclosed CGTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)371.70K sh
Reported value held$427.46K
Portfolio Weight0.34%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Dauntless Investment Group, LLC's CGTX position evolved

Dauntless Investment Group, LLC first disclosed a stake in CGTX in Q4 2025 at 466,000 shares (US$629K). Across 3 filings, Dauntless Investment Group, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 371,701 shares valued at US$427K — a reduction of -59,299 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 466.00K $629.10K New
Q1 2026 431.00K $327.35K Reduce
Q2 2026 371.70K $427.46K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGTX and 13F data

CGTX (COGNITION THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in CGTX — the largest reported positions include BIOS Capital Management, LP (US$6.9M), Chescapmanager LLC (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGTX

All CGTX fund holders →

FAQ

How long has Dauntless Investment Group, LLC held CGTX?

Dauntless Investment Group, LLC has disclosed CGTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Dauntless Investment Group, LLC's current position in CGTX?

As of Q2 2026, Dauntless Investment Group, LLC holds 371.70K shares of CGTX (COGNITION THERAPEUTICS INC), valued at $427.46K, representing 0.34% of its reported portfolio and ranking #39.

Has Dauntless Investment Group, LLC been buying or selling CGTX?

In the latest 13F filing (Q2 2026), Dauntless Investment Group, LLC reduced its position in CGTX.

Which other funds hold CGTX?

Other major institutional holders of CGTX include BIOS Capital Management, LP, Chescapmanager LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.